Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test TEL/AML Quantitative Test is 5 business days.

What are the prerequisites for the test TEL/AML Quantitative Test

  • Basic knowledge of mathematics including algebra, calculus, and statistics
  • Understanding of quantitative analysis and data interpretation
  • Familiarity with financial markets and investment principles
  • Ability to use financial modeling and quantitative tools
  • Proficiency in Excel and other relevant software programs

What are the measure values for the test TEL/AML Quantitative Test

  • Positive: Greater than 5.0 copies of TEL/AML1 fusion transcript per 10^4 ABL copies
  • Borderline: 1.0-5.0 copies of TEL/AML1 fusion transcript per 10^4 ABL copies
  • Negative: Less than 1.0 copies of TEL/AML1 fusion transcript per 10^4 ABL copies

What does this test TEL/AML Quantitative Test identify?

TEL/AML Quantitative Test

The TEL/AML Quantitative Test is a diagnostic test used to identify specific gene mutations associated with certain types of leukemia, specifically T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML). The test quantitatively measures the presence of the TEL-AML1 fusion gene, which is a genetic abnormality resulting from a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21.

Identifying the TEL-AML1 fusion gene is important for diagnosing and monitoring patients with T-ALL, as it is a specific marker for this subtype of leukemia. The test results can help guide treatment decisions and monitor the effectiveness of therapy.

Why is this test TEL/AML Quantitative Test taken?

The TEL/AML Quantitative Test is taken to monitor the levels of TEL/AML fusion transcripts in patients with certain types of leukemia, specifically acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). These fusion transcripts are the result of genetic abnormalities that are commonly found in these types of leukemia. By measuring the levels of TEL/AML fusion transcripts in a patient's blood or bone marrow, healthcare providers can assess the effectiveness of treatment, monitor disease progression, and make informed decisions about the patient's care.

No FAQs available.

Customer Google Rating